assemblybio.com (ASMB): היקף יתרות המזומנים של החברה

לוגו גרפי של assemblybio.com (ASMB)

Assembly Biosciences is developing advanced methods to combat hepatitis B by investing in scientific research. The cash position demonstrates current liquidity, where the parameter value equals 0.31. The stability of US assets minimizes external risks. Meanwhile, the company's strategy relies on partnerships to optimize costs while creating therapies that block viral replication.

יתרות המזומנים של החברה: Assembly Corp (ASMB) עבור 04.07.2022 - 21.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור Assembly Biosciences, Inc. (ASMB)

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח כללי של החברה:assemblybio.com
דוגמת מוצר של assemblybio.com

Developing long-acting antiviral drugs requires significant capital expenditures and strategic resource allocation. This indicator aggregates all highly liquid assets, determining the business's financial autonomy in creating liver disease medications. A sufficient cash reserve prevents liquidity gaps and reduces dependence on external financing. By analyzing the cash balance on the balance sheet, an investor assesses the ability of Assembly Biosciences (ASMB) management to maintain operational stability.